Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Velocity Clinical Research - Union, South Carolina

Verified

Basic Information

Site Overview

Source: Human-provided.

Velocity Clinical Research – Union is a dedicated clinical trial research site located in Union, South Carolina, United States. The facility is part of the global Velocity Clinical Research network, an integrated site organization that partners with pharmaceutical, biotechnology, and medical device companies to conduct clinical trials for the development of new medicines and innovative healthcare solutions. The Union site conducts Phase II–IV clinical trials across a variety of therapeutic areas, including internal medicine, vaccines, infectious diseases, endocrinology, cardiology, and metabolic disorders. The research center collaborates with experienced physician investigators, clinical research coordinators, and trained healthcare professionals to ensure that studies are conducted in accordance with international regulatory standards and ethical clinical research practices. Equipped with modern clinical research infrastructure such as patient consultation rooms, laboratory…

Source: Trial-derived.
12Total Trials
Source: Trial-derived.
2Recruiting Trials
Source: Trial-derived.
6Active Trials
Source: Trial-derived.
6Completed Trials
Source: Trial-derived.
12Unique Conditions
Source: Trial-derived.
16Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. COVID-19 (2)Source: Trial-derived. Diabetes Mellitus, Type 2 (2)Source: Trial-derived. Hypertension (2)Source: Trial-derived. Cardiovascular Diseases (1)Source: Trial-derived. Chronic Obstructive Pulmonary Disease (1)Source: Trial-derived. COPD (1)Source: Trial-derived. Influenza, Human (1)Source: Trial-derived. Non-cystic Fibrosis Bronchiectasis (1)

Sponsors

Source: Trial-derived. Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA (3)Source: Trial-derived. Boehringer Ingelheim (2)Source: Trial-derived. AbCellera Biologics Inc. (1)Source: Trial-derived. Eli Lilly and Company (1)Source: Trial-derived. Exeltis (1)Source: Trial-derived. GlaxoSmithKline (1)Source: Trial-derived. IQVIA Pty Ltd (1)Source: Trial-derived. Laboratorios Liconsa (1)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Clinical microbiology culture
Source: AI-inferred. PCR / molecular

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Cardiac monitoring
Source: AI-inferred. Hemagglutination inhibition (HI) serology assay